Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
By A Mystery Man Writer
Description
Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
Sara Hägg Karolinska Institutet
Effects of blood pressure and antihypertensive drugs on osteoarthritis: a mendelian randomized study
Functional role of PPAR-γ on the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis
Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
Causal effect of renal function on venous thromboembolism: a two-sample Mendelian randomization investigation
Molecular epidemiology of aging – Sara Hägg's research group
Leonid Padyukov Karolinska Institutet
Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
Overview of the Mendelian randomization study design. The Mendelian
Estimated effects of genetic variation(s) in antidiabetic drug targets
Splicing of PADI4 contributes to RA risk.
Overview of the Mendelian randomization study design. The Mendelian
Overview of the Mendelian randomization study design. The Mendelian
PDF) Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
from
per adult (price varies by group size)